Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of bacterial and viral pathogen-associated molecular patterns (PAMPs) on multidrug resistance (MDR) transporters in brain endothelial cells of the developing human blood-brain barrier. | Fluids Barriers CNS | 2023 | 36721242 | PubTator, text mining | PubMed |
| Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development. | BMC Cancer | 2023 | 36707804 | PubTator, text mining | PubMed |
| Centromeres as universal hotspots of DNA breakage, driving RAD51-mediated recombination during quiescence. | Mol Cell | 2023 | 36702125 | PubTator, text mining | PubMed |
| Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry. | PLoS Pathog | 2023 | 36701392 | PubTator, text mining | PubMed |
| N-terminal domain of tyrosyl-DNA phosphodiesterase I regulates topoisomerase I-induced toxicity in cells. | Sci Rep | 2023 | 36697463 | PubTator, text mining | PubMed |
| A CRISPR-Cas9 screen identifies EXO1 as a formaldehyde resistance gene. | Nat Commun | 2023 | 36693839 | PubTator, text mining | PubMed |
| SPRTN patient variants cause global-genome DNA-protein crosslink repair defects. | Nat Commun | 2023 | 36681662 | PubTator, text mining | PubMed |
| The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy. | Pharmaceuticals (Basel) | 2023 | 36678591 | PubTator, text mining | PubMed |
| Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies. | Int J Mol Sci | 2023 | 36675253 | PubTator, text mining | PubMed |
| The Advancement of Biodegradable Polyesters as Delivery Systems for Camptothecin and Its Analogues-A Status Report. | Int J Mol Sci | 2023 | 36674567 | PubTator, text mining | PubMed |
| Influence of Tyrosyl-DNA Phosphodiesterase 1 Inhibitor on the Proapoptotic and Genotoxic Effects of Anticancer Agent Topotecan. | Dokl Biochem Biophys | 2023 | 36653585 | PubTator, text mining | PubMed |
| Evolution of TOP1 and TOP1MT Topoisomerases in Chordata. | J Mol Evol | 2023 | 36651963 | PubTator, text mining | PubMed |
| Targeting RNA:protein interactions with an integrative approach leads to the identification of potent YBX1 inhibitors. | Elife | 2023 | 36651723 | PubTator, text mining | PubMed |
| ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen. | Cell Rep | 2023 | 36640339 | PubTator, text mining | PubMed |
| New Life of Topoisomerase I Inhibitors as Antibody-Drug Conjugate Warheads. | Clin Cancer Res | 2023 | 36637483 | PubTator, text mining | PubMed |
| Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | J Biol Chem | 2023 | 36634849 | PubTator, text mining | PubMed |
| G4-interacting proteins endangering genomic stability at G4 DNA-forming sites. | Biochem Soc Trans | 2023 | 36629511 | PubTator, text mining | PubMed |
| Cluster-based text mining for extracting drug candidates for the prevention of COVID-19 from the biomedical literature. | J Taibah Univ Med Sci | 2023 | 36618881 | PubTator, text mining | PubMed |
| Onco-immunity and therapeutic application of amygdalin: A review. | J Oral Biol Craniofac Res | 2023 | 36618007 | PubTator, text mining | PubMed |
| The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options. | Cell Oncol (Dordr) | 2023 | 36598637 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=37